Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Tacrolimus × 30 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Myeloid, Acute 4 Lymphoma 3 Primary Myelofibrosis 2 Myeloproliferative Disorders 2 Myelodysplastic Syndromes 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphoid 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hematologic Neoplasms 2 Anemia, Refractory, with Excess of Blasts 2 beta-Thalassemia 1 Thalassemia 1 Shwachman-Diamond Syndrome 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Preleukemia 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Neoplasms by Histologic Type 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Lymphoproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphatic Diseases 1 Leukemia, Myeloid 1 Leukemia, Monocytic, Acute 1

Interventions

pembrolizumab 2 fludarabine 2 blinatumomab 2 tislelizumab 1 tisagenlecleucel 1 tetrathiomolybdate 1 relugolix 1 nilotinib 1 isatuximab 1 inavolisib 1 giredestrant 1 fludarabine phosphate 1 enzalutamide 1 abemaciclib 1 Transplantation 1 Monatide (IMS 3015) 1 Melphalan 1 Lenalidomide 1 Immunotherapy 1 Imatinib Mesylate 1 HMPL-013 1 Docetaxel 1 Dexamethasone 1 Dasatinib 1 Cyclophosphamide 1 Capecitabine 1 Calcium Dobesilate 1 Biological Assay 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡